TherapeuticsMD, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
TherapeuticsMD, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q2 2024.
  • TherapeuticsMD, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $1.39M, a 2297% increase year-over-year.
  • TherapeuticsMD, Inc. annual Nonoperating Income (Expense) for 2023 was $781K.
  • TherapeuticsMD, Inc. annual Nonoperating Income (Expense) for 2022 was -$117K, a 143% decline from 2021.
  • TherapeuticsMD, Inc. annual Nonoperating Income (Expense) for 2021 was $272K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $1.39M +$1.33M +2297% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q4 2023 $781K $27K -$22.8M -99.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 $23.6M $339K +$451K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $23.1M $58K +$74K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $23M $357K +$23.1M Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$117K $22.8M -$2.55M -10% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 $2.43M -$112K +$7.39M +98.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$4.96M -$16K +$7.46M +99.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$12.4M -$22.8M -$12.7M -126% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $272K $25.3M +$32.8M Oct 1, 2021 Dec 31, 2021 10-K 2023-04-07
Q3 2021 -$32.6M -$7.5M +$139K +1.82% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$32.7M -$7.47M -$535K -7.71% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$32.2M -$10.1M -$4.18M -70.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$28M -$7.48M -$2.44M -48.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 -$25.5M -$7.64M -$2.74M -56% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$22.8M -$6.94M +$6.66M +49% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 -$29.5M -$5.93M -$4.53M -323% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$24.9M -$5.04M -$3.77M -297% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-23
Q3 2019 -$21.2M -$4.9M -$3.65M -293% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$17.5M -$13.6M -$13.4M -6798% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 -$4.11M -$1.4M -$1.72M -545% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$2.4M -$1.27M -$1.52M -602% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-04
Q3 2018 -$873K -$1.24M -$1.41M -844% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $538K -$197K -$350K -229% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $888K $315K +$185K +142% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $703K $253K +$149K +143% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-24
Q3 2017 $554K $167K +$54.9K +48.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $500K $153K +$35.7K +30.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-30
Q1 2017 $464K $130K +$85.7K +194% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
Q4 2016 $378K $104K +$78.1K +297% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $300K $112K +$82K +270% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $218K $117K +$89K +316% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $129K $44.2K +$15.8K +55.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $113K $26.3K +$13.6K +107% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-23
Q3 2015 $99.6K $30.4K +$14.8K +94.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $84.8K $28.1K +$328 +1.18% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $84.5K $28.4K +$261K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 -$176K $12.7K +$362K Oct 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q3 2014 -$539K $15.6K +$452K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 -$990K $27.8K +$420K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$1.41M -$232K +$1.2M +83.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$2.61M -$350K -$17.5K -5.28% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 -$2.59M -$436K -$93.3K -27.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 -$2.5M -$393K +$7.48M +95% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$9.98M -$1.43M +$8.99M +86.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 -$19M -$332K +$7.09M +95.5% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-12
Q3 2012 -$26.1M -$343K -$300K -706% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-05
Q2 2012 -$25.8M -$7.88M -$7.86M -50491% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 -$17.9M -$10.4M -$10.4M -356315% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 -$7.49M -$7.43M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-05
Q3 2011 -$42.5K +$13.1K +23.5% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$15.6K -$7.07K -83.2% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$2.92K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
Q3 2010 -$55.6K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 -$8.5K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.